Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals
Authors:
Open Access
- 16 June 2025
- journal article
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 49 (7) , 102639
Abstract
No abstract availableKeywords
Funding Information
- Santé (366391)
- Public Health Agency of Canada
- Canadian Institutes of Health Research (NPC-178912)
This publication has 46 references indexed in Scilit:
- Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antiviralsJournal of Gastroenterology, 2024
- Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antiviralsJournal of Gastroenterology, 2024
- Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis CHepatology Communications, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Serial changes in liver stiffness and controlled attenuation parameter following direct‐acting antiviral therapy against hepatitis C virus genotype 1bJournal of Medical Virology, 2017
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver diseaseHepatology, 2015
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic FibrosisJAMA, 2012
- Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006